Bulletin
Investor Alert

London Markets Open in:

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201531540/composite

$

291.00

Change

+1.68 +0.58%

Volume

Volume 24,361

Sep 22, 2021, 7:55 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201531540/composite

Previous close

$ 295.54

$ 289.32

Change

-6.22 -2.10%

Day low

Day high

$285.40

$292.17

Open
Open: 289.44

52 week low

52 week high

$223.25

$468.55

Open

Market cap

$44.05B

Average volume

1.06M

P/E ratio

23.21

Rev. per Employee

$1.36M

EPS

12.47

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. Nike, Costco, FedEx, Salesforce, and Other Stocks to Watch

    7:38 a.m. Sept. 20, 2021

    - Nicholas Jasinski

  2. 5 Biotech Stocks That Could Lead a Revival

    2:03 p.m. Sept. 6, 2021

    - Josh Nathan-Kazis

  3. Biogen Is Giving Away Its Controversial Alzheimer's Drug: Report

    11:14 a.m. Aug. 30, 2021

    - Josh Nathan-Kazis

  4. Early Sales of Biogen's Alzheimer Drug Remain Unclear

    11:48 a.m. Aug. 26, 2021

    - Josh Nathan-Kazis

  5. Not Your Traditional Value Fund

    6:00 a.m. Aug. 26, 2021

    - Debbie Carlson

  6. Warren Buffett's Berkshire Hathaway Sold Its Entire Axalta Stake

    2:04 p.m. Aug. 17, 2021

    - Nicholas Jasinski

  7. Berkshire Hathaway Cuts Stakes in Drugmakers, GM

    7:19 p.m. Aug. 16, 2021

    - Andrew Bary

  8. Eli Lilly Stock Is Soaring. Sales Bounced Back.

    1:28 p.m. Aug. 3, 2021

    - Bill Alpert

  9. Bristol Myers Squibb Stock Rises After Modest Earnings Beat

    10:08 a.m. July 28, 2021

    - Josh Nathan-Kazis

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. Apple iPhone Features Would Detect Depression, Cognitive Decline

    1:07 p.m. Sept. 21, 2021

    - Rolfe Winkler

  2. Is Now the Time to Ditch Pharma Stocks?

    6:45 a.m. Sept. 21, 2021

    - Motley Fool

  3. Big Pharma Stocks Hit Hard by Drug Price Proposals

    3:42 p.m. Sept. 20, 2021

    - GuruFocus.com

  4. Eisai: Aduhelm Does Not Look Like A Major Drug Against Alzheimer's

    11:09 a.m. Sept. 20, 2021

    - Seeking Alpha

  5. FDA approves Samsung Bioepis and Biogen’s Byooviz

    7:56 a.m. Sept. 20, 2021

    - Seeking Alpha

  6. Ginkgo Bioworks Goes Public After Closing SPAC Merger

    7:54 p.m. Sept. 17, 2021

    - Brian Gormley

  7. Biogen (BIIB) Reports Mixed Data From Neuropathy Pain Study

    10:58 a.m. Sept. 17, 2021

    - Zacks.com

  8. Alzheimer's Drug for Roche Partner AC Immune Shows Promise

    1:54 p.m. Sept. 16, 2021

    - GuruFocus.com

  9. Biogen announces mixed results from a mid-stage pain study

    7:54 a.m. Sept. 16, 2021

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. Biogen Inc. Common Stock BIIB Buy and Sell Signals

    12:48 a.m. July 30, 2021

    - Stock Traders Daily

  2. Liver Fibrosis Drug Market Size Set to Register 13290 million USD by 2025

    9:50 a.m. July 23, 2021

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.